What is the truth behind pump thrombosis in the HeartMate II device? A National Heart, Lung, and Blood Institute perspective based on data from the Interagency Registry for Mechanically Assisted Circulatory Support.

Abstract

The clinical community faces major issues in caring for the 100,000 to 300,000 advanced heart failure patients in the United States. For these patients, left ventricular assist devices (LVADs) may provide life-saving options for use as destination therapy or as a bridge to heart transplantation. Emerging and changing patterns of adverse events in continuous… (More)
DOI: 10.1016/j.healun.2015.10.036

6 Figures and Tables

Topics

  • Presentations referencing similar topics